Ernexa Therapeutics, Inc. (ERNA)
0.2821
0.00 (0.00%)
USD |
NASDAQ |
Mar 09, 14:05
Ernexa Therapeutics SG&A Expense (TTM) : 5.284M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 118.30M |
| Quince Therapeutics, Inc. | 15.70M |
| Recursion Pharmaceuticals, Inc. | 176.59M |
| Tango Therapeutics, Inc. | 31.74M |
| Aprea Therapeutics, Inc. | 5.912M |